Treasury & Bonds
View Full List
Dow Jones Industrial Average
Standard & Poors 500
NYSE COMPOSITE INDX
MarketMinute.com Stock News
September 17, 2012 at 13:36 PM EDT
Threshold Reports Statistically Insignificant Results
Threshold Pharmaceuticals Inc. (
) reported that the median survival of patients treated with TH-302 and gemcitabine compared with gemcitabine alone was not statistically significant sending the stock price plummeting $1.69 to $7.03.
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Terms and Conditions
Press Release Service
provided by PRConnect.
Stock quotes supplied by Six Financial
Bots go here